Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death
Open Access
- 14 November 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (22) , 9062-9072
- https://doi.org/10.1158/0008-5472.can-10-1825
Abstract
Clinical findings confirm expectations of a stringent correlation between the therapeutic efficacy of a dendritic cell vaccine and the extent of immunogenic death induced in the tumor cells used to load the dendritic cells before vaccination.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer ImmunityCancer Research, 2010
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell deathThe EMBO Journal, 2009
- Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot studyBlood, 2009
- The anticancer immune response: indispensable for therapeutic success?Journal of Clinical Investigation, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Molecular characteristics of immunogenic cancer cell deathCell Death & Differentiation, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaCancer Immunology, Immunotherapy, 2007
- Bortezomib enhances dendritic cell (DC)–mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implicationsBlood, 2007
- Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cellsExperimental Cell Research, 2005